Moleculin Announces Positive Interim Results in First Cohort of Phase 1/2 Clinical Studies of Annamycin in Acute Myeloid Leukemia in the US and in Poland Mar 26, 2019
Moleculin Announces Memorial Sloan Kettering Chief of Leukemia Joins Science Advisory Board Mar 18, 2019
Moleculin Biotech, Inc. to Present at the Oppenheimer 29th Annual Healthcare Conference and the 31st Annual ROTH Conference Mar 18, 2019
Moleculin Announces Outlicensing Deal To Accelerate Preclinical and Clinical Development Feb 20, 2019
